表紙
市場調查報告書

全球血漿市場(免疫球蛋白,白蛋白,第八凝血因子,Alpha-1)洞察,趨勢,預測

Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023)

出版商 Koncept Analytics 商品編碼 897440
出版日期 內容資訊 英文 109 Pages
訂單完成後即時交付
價格
Back to Top
全球血漿市場(免疫球蛋白,白蛋白,第八凝血因子,Alpha-1)洞察,趨勢,預測 Global Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1): Insights, Trends and Forecast (2019-2023)
出版日期: 2019年07月30日內容資訊: 英文 109 Pages
簡介

本報告提供全球血漿市場調查,市場概要,各市場區隔的市場預測,市場成長要素及課題分析,競爭情形,主要企業的簡介等全面性資訊。

第1章 市場概要

  • 血漿
  • 血漿分餾流程
  • 血漿衍生物
  • 血漿功能
  • 等離子收集

第2章 全球市場分析

  • 血漿市場(以金額為準)
  • 血漿市場預測(以金額為準)
  • 血漿分餾容量(公升為基礎)
  • 血漿分餾產能預測
  • 血漿分餾容量:各類型
  • 血漿分餾產能預測:各類型
  • 血漿市場:各類型
  • 血漿市場預測:各類型
  • 免疫球蛋白市場
  • 白蛋白市場
  • 第八凝血因子
  • Alpha-1
  • 血漿市場:各地區

第3章 地區市場分析

  • 北美
    • 血漿市場預測
    • 血漿市場:各類型
    • 美國的免疫球蛋白市場預測(以金額、重量為準)
    • 美國的免疫球蛋白市場:各市場區隔
    • 美國的白蛋白市場預測
    • 美國的原料血漿採取市場
    • 美國的原料血漿採取市場預測
  • 歐洲
    • 歐洲的血漿市場預測
  • 亞太地區
    • 亞太地區的血漿市場預測

第4章 市場動態

  • 成長促進因素
  • 市場趨勢
  • 課題

第5章 競爭情形

  • 全球市場
    • 收益及市值比較
    • 研究開發支出比較
    • 全球血漿市場佔有率
    • 全球免疫球蛋白市場佔有率
    • 全球白蛋白市場佔有率
    • 全球血漿來源第八凝血因子市場佔有率
    • Alpha-1市場佔有率
    • 主要企業的血漿採取的增加
  • 美國
    • 美國的血漿採取中心:各主要企業
    • 美國的血漿採取數量:各主要企業

第6章 企業簡介

  • 武田藥品工業
  • CSL Limited
  • Frifols, S.A.
  • Octapharma, Inc.
  • ADMA Biologics, Inc.
  • China Biologics Product Holdings
目錄

The global blood plasma market is estimated to reach US$29.50 billion in 2023, growing at a CAGR of 7% for the period spanning from 2019 to 2023. The factors such as progress in therapeutic protein development, new advances in production of plasma, growing aging population, increasing spending on medicines and rise in collection centers are expected to drive the market. However, growth of the industry will be challenged by high cost of treatment, and high R&D costs. A few notable trends include increase in fractionation capacity, and innovation in therapeutics.

The global blood plasma market is broadly segmented into four types which are Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others. Increased recognition and treatment of primary immunodeficiency (PI), use in new indications, and increasing consumption in low IG-use countries has driven the growth of immunoglobulin segment.

North America is the largest market for blood plasma due to its advanced infrastructure which has helped in increasing plasma collection over the time. The emerging economies like China have showed huge potential with increased imports of Albumin. Rising use of immunoglobulin and increasing incidence of immune and bleeding disorders propelled the demand for immunoglobulin in the Unites States.

Scope of the report:

The report provides a comprehensive analysis of the global blood plasma market, segmented into Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others.

The major regional markets (North America, Europe and APAC) have been analyzed, along with country coverage of the United States.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Takeda Pharmaceutical, CSL Limited, Grifols S.A., Octapharma, Inc., ADMA Biologics and China Biologics) are also presented in detail.

Key Target Audience:

  • Blood Plasma Products Manufacturers
  • End Users (Hospitals, Medical Centers & Clinical Institutes)
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Table of Contents

1. Market Overview

  • 1.1 Blood Plasma
  • 1.2 Blood Plasma Fractionation Process
  • 1.3 Blood Plasma Derivatives
  • 1.4 Functions of Blood Plasma
  • 1.5 Plasma Collection

2. Global Market Analysis

  • 2.1 Global Blood Plasma Market by Value
  • 2.2 Global Blood Plasma Market Forecast by Value
  • 2.3 Global Blood Plasma Fractionation Capacity
  • 2.4 Global Blood Plasma Fractionation Capacity Forecast
  • 2.5 Global Blood Plasma Fractionation Capacity by Type
  • 2.6 Global Blood Plasma Fractionation Capacity Forecast by Type
  • 2.7 Global Blood Plasma Market by Type
  • 2.8 Global Blood Plasma Market Forecast by Type
  • 2.9 Global Immunoglobulin Market
    • 2.9.1 Global Immunoglobulin Market Forecast by Value
    • 2.9.2 Global Immunoglobulin Market Forecast by Volume
    • 2.9.3 Global Immunoglobulin Market Volume by Region
    • 2.9.4 Global Immunoglobulin Market by Types
    • 2.9.5 Global Immunoglobulin Population by Indication
  • 2.10 Global Albumin Market
    • 2.10.1 Global Albumin Market Forecast by Value
    • 2.10.2 Global Albumin Market Forecast by Volume
    • 2.10.3 Global Albumin Market Volume by Region
  • 2.11 Global Factor VIII Market
    • 2.11.1 Global Factor VIII Market Forecast by Value
    • 2.11.2 Global Factor VIII Market Forecast by Volume
  • 2.12 Global Alpha 1 Market
    • 2.12.1 Global Alpha 1 Market Forecast by Value
  • 2.13 Global Blood Plasma Market by Region

3. Regional Analysis

  • 3.1 North America
    • 3.1.1 North America Blood Plasma Market Forecast by Value
    • 3.1.2 North America Blood Plasma Market by Type
    • 3.1.3 The US Immunoglobulin Market Forecast by Value & Volume
    • 3.1.4 The US Immunoglobulin Market Volume by Segment
    • 3.1.5 The US Albumin Market Forecast by Volume
    • 3.1.6 The US Source Plasma Collection Volume
    • 3.1.7 The US Source Plasma Collection Volume Forecast
  • 3.2 Europe
    • 3.2.1 Europe Blood Plasma Market Forecast by Value
  • 3.3 APAC
    • 3.3.1 Asia-Pacific Blood Plasma Market Forecast by Value

4. Market Dynamics

  • 4.1 Growth Drivers
    • 4.1.1 Recent Progress in Therapeutic Protein Drug Development
    • 4.1.2 Developments in the Production of Plasma Derivatives
    • 4.1.3 Increasing Plasma Collection
    • 4.1.4 Increase in Per Capita use of Immunoglobulin
    • 4.1.5 Rise in GDP Per Capita
    • 4.1.6 Increased Spending on Medicines
    • 4.1.7 Increasing Global Healthcare Expenditure
    • 4.1.8 Escalating Ageing Population
  • 4.2 Trends & Developments
    • 4.2.1 Increasing Fractionation Capacity
    • 4.2.2 Growing Blood Plasma Market in Emerging Economies
  • 4.3 Challenges & Issues
    • 4.3.1 High Barriers to Entry
    • 4.3.2 Challenging to Open New Plasma Centers
    • 4.3.3 High R&D Costs

5. Competitive Landscape

  • 5.1 Global Market
    • 5.1.1 Revenue and Market Cap Comparison
    • 5.1.2 Research & Development Expenditure Comparison
    • 5.1.3 Global Blood Plasma Market Share
    • 5.1.4 Global Immunoglobulin Market Share
    • 5.1.5 Global Albumin Market Share
    • 5.1.6 Global Plasma-Derived Factor VIII Market Share
    • 5.1.7 Global Alpha1 Market Share
    • 5.1.8 Growth in Plasma Collection by Leading Players
  • 5.2 The US
    • 5.2.1 The US Blood Plasma Collection Centers by Major Players
    • 5.2.2 The US Blood Plasma Collection Volume by Major Players

6. Company Profiles

  • 6.1 Takeda Pharmaceutical (Shire Plc.)
    • 6.1.1 Business Overview
    • 6.1.2 Financial Overview
    • 6.1.3 Business Strategies
  • 6.2 CSL Limited
    • 6.2.1 Business Overview
    • 6.2.2 Financial Overview
    • 6.2.3 Business Strategies
  • 6.3 Grifols, S.A.
    • 6.3.1 Business Overview
    • 6.3.2 Financial Overview
    • 6.3.3 Business Strategies
  • 6.4 Octapharma, Inc.
    • 6.4.1 Business Overview
    • 6.4.2 Financial Overview
    • 6.4.3 Business Strategies
  • 6.5 ADMA Biologics, Inc.
    • 6.5.1 Business Overview
    • 6.5.2 Financial Overview
    • 6.5.3 Business Strategies
  • 6.6 China Biologics Product Holdings
    • 6.6.1 Business Overview
    • 6.6.2 Financial Overview
    • 6.6.3 Business Strategies

List of Figures

  • Components of Blood Plasma
  • Blood Plasma Fractionation Process
  • Plasma Fractioned to Protein
  • Global Blood Plasma Market by Value (2014-2018)
  • Global Blood Plasma Market Forecast by Value (2019-2023)
  • Global Blood Plasma Fractionation Capacity (2014-2018)
  • Global Blood Plasma Fractionation Capacity Forecast (2019-2023)
  • Global Blood Plasma Fractionation Capacity by Type (2014-2018)
  • Global Blood Plasma Fractionation Capacity Forecast by Type (2019-2023)
  • Global Blood Plasma Market by Type (2018)
  • Global Blood Plasma Market Forecast by Type (2023)
  • Global Immunoglobulin Market Forecast by Value (2018-2023)
  • Global Immunoglobulin Market Forecast by Volume (2018-2023)
  • Global Immunoglobulin Market Volume by Region (2018)
  • Global Immunoglobulin Market by Types (2018)
  • Global Immunoglobulin Population by Indication (2018)
  • Global Albumin Market Forecast by Value (2018-2023)
  • Global Albumin Market Forecast by Volume (2018-2023)
  • Global Albumin Market Volume by Region (2018)
  • Global Factor VIII Market Forecast by Value (2018-2023)
  • Global Factor VIII Market Forecast by Volume (2018-2023)
  • Global Alpha 1 Market Forecast by Value (2018-2023)
  • Global Blood Plasma Market by Region (2018)
  • North America Blood Plasma Market Forecast by Value (2018-2023)
  • North America Blood Plasma Market by Type (2018)
  • The US Immunoglobulin Market Forecast by Value & Volume (2018-2023)
  • The US Immunoglobulin Market Volume by Segment (2018)
  • The US Albumin Market Forecast by Volume (2018-2023)
  • The US Source Plasma Collection Volume (2014-2018)
  • The US Source Plasma Collection Volume Forecast (2019-2023)
  • Europe Blood Plasma Market Forecast by Value (2018-2023)
  • Asia-Pacific Blood Plasma Market Forecast by Value (2018-2023)
  • Plasma Collection in the US (2014-2018)
  • Per Capita use of Immunoglobulin by Region (2018)
  • Global GDP Per Capita (2014-2018)
  • Global Spending on Medicines (2010-2020)
  • Global Healthcare Expenditure (2014-2018)
  • Global Ageing Population of 60 Years or Older (2014-2018)
  • Global Blood Plasma Market Share by Company (2018)
  • Global Immunoglobulin Market Share by Company (2018)
  • Global Albumin Market Share by Company (2018)
  • Global Plasma-Derived Factor VIII Market Share by Company (2018)
  • Global Alpha1 Market Share by Company (2018)
  • Growth in Plasma Collection by Leading Players (2014-2018)
  • The US Blood Plasma Collection Centers by Major Players (2014-2018)
  • The US Blood Plasma Collection Volume by Major Players (2014-2018)
  • Takeda Pharmaceutical Revenue Share by Product (2019)
  • Takeda Pharmaceutical Revenue Share by Geographic Region (2019)
  • Takeda Pharmaceutical Revenue and Net Profit (2015-2019)
  • CSL Limited Revenue Share by Segments (2018)
  • CSL Limited Sales and Net Profit (2014-2018)
  • Grifols, S.A. Revenue Share by Business Segments (2018)
  • Grifols, S.A. Revenue Share by Geographic Region (2018)
  • Grifols, S.A. Revenue and Profit (2014-2018)
  • Octapharma, Inc. Revenue and Net Profit (2014-2018)
  • ADMA Biologics Revenue Share by Business Segments (2018)
  • ADMA Biologics Revenue and Net Loss (2014-2018)
  • China Biologics Revenue Share by Business Segments (2018)
  • China Biologics Revenue and Net Income (2014-2018)

List of Tables

  • Blood Plasma Protein Breakup
  • Functions of Blood Plasma
  • Protein Engineering Platform Technologies (2018)
  • The US Food and Drug Administration-Approved IG Products (2018)
  • Fractionation Capacity of Key Market Players (2013-2022)
  • Key Players - Revenue & Market Cap Comparison (2018)
  • Key Players - Research & Development Expenditure Comparison (2018)
Back to Top